WELLINGTON MANAGEMENT GROUP LLP - PDL BIOPHARMA INC ownership

PDL BIOPHARMA INC's ticker is PDLI and the CUSIP is 69329Y104. A total of 199 filers reported holding PDL BIOPHARMA INC in Q2 2013. The put-call ratio across all filers is 0.29 and the average weighting 0.1%.

Quarter-by-quarter ownership
WELLINGTON MANAGEMENT GROUP LLP ownership history of PDL BIOPHARMA INC
ValueSharesWeighting
Q3 2018$558,000
-84.1%
212,287
-85.9%
0.00%
-100.0%
Q2 2018$3,516,000
-20.5%
1,502,485
-0.0%
0.00%0.0%
Q1 2018$4,420,000
+10.6%
1,503,153
+3.0%
0.00%0.0%
Q4 2017$3,998,000
-19.2%
1,459,1330.0%0.00%0.0%
Q3 2017$4,947,000
+30.4%
1,459,133
-5.0%
0.00%0.0%
Q2 2017$3,794,000
+5.4%
1,535,837
-3.1%
0.00%0.0%
Q1 2017$3,599,000
+6.7%
1,585,544
-0.4%
0.00%0.0%
Q4 2016$3,374,000
-24.5%
1,591,250
+19.3%
0.00%0.0%
Q3 2016$4,467,000
+6.8%
1,333,446
+0.1%
0.00%0.0%
Q2 2016$4,184,000
-5.7%
1,332,5040.0%0.00%0.0%
Q1 2016$4,437,000
-5.9%
1,332,5040.0%0.00%0.0%
Q4 2015$4,717,000
+9.1%
1,332,504
+55.0%
0.00%0.0%
Q3 2015$4,325,000
-14.3%
859,797
+9.5%
0.00%0.0%
Q2 2015$5,049,000
+4.9%
785,309
+14.7%
0.00%0.0%
Q1 2015$4,815,000
+21.0%
684,467
+32.7%
0.00%0.0%
Q4 2014$3,978,000
+5.7%
515,955
+2.4%
0.00%0.0%
Q3 2014$3,763,000
+26.1%
503,734
+63.4%
0.00%0.0%
Q2 2014$2,984,000
-50.2%
308,200
-57.3%
0.00%
-50.0%
Q1 2014$5,995,000
+3.7%
721,435
+5.3%
0.00%0.0%
Q4 2013$5,783,000
+21.8%
685,135
+15.1%
0.00%
+100.0%
Q3 2013$4,746,000
+10.1%
595,435
+6.7%
0.00%0.0%
Q2 2013$4,309,000558,1350.00%
Other shareholders
PDL BIOPHARMA INC shareholders Q2 2013
NameSharesValueWeighting ↓
KESTREL INVESTMENT MANAGEMENT CORP 1,634,000$4,804,0001.81%
SMH CAPITAL ADVISORS INC 80,722$237,0000.37%
Matarin Capital Management, LLC 1,126,641$3,312,325,0000.25%
Hillsdale Investment Management Inc. 337,800$993,0000.14%
Zebra Capital Management LLC 115,431$339,0000.12%
Connor, Clark & Lunn Investment Management Ltd. 4,789,702$14,082,0000.08%
Fortis Advisors, LLC 45,602$134,0000.07%
Municipal Employees' Retirement System of Michigan 500,080$1,470,0000.07%
RBF Capital, LLC 173,090$508,0000.06%
GSA CAPITAL PARTNERS LLP 392,276$1,153,0000.06%
View complete list of PDL BIOPHARMA INC shareholders